Optimizing Biologic and Conventional Therapies for Inflammatory Bowel Disease

Stephen B. Hanauer, MD, a world-renowned expert in IBD, discusses the latest advances in IBD treatment, including the evolving role of conventional therapy and expanding the role of biologic therapy. Hanauer also shares his research on the efficacy of adalimumab and study of higher versus standard adalimumab dosing regimens in patients with moderate to severely active ulcerative colitis.